Signal transduction in mammary tumorigenesis: a transgenic perspective.
about
Contribution of CXCL12 secretion to invasion of breast cancer cells.Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis.MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancerA requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 miceThe receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signalingDisruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.Initiating oncogenic event determines gene-expression patterns of human breast cancer modelsTransgenic mouse models of human breast cancer.Genetically engineered rodent models of mammary gland carcinogenesis: an overview.Shc is required for ErbB2-induced inhibition of apoptosis but is dispensable for cell proliferation and disruption of cell polarityProgression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.Cell transformation by the middle T-antigen of polyoma virus.Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2Lessons from the alpha2 integrin knockout mouse.Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications.Molecular markers and therapeutic targets in ductal carcinoma in situ.Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo.Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene.Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesisEts2-dependent stromal regulation of mouse mammary tumorsRab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor ProgressionGerm-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesisMyosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation.Characterization of a P-Rex1 gene signature in breast cancer cellsSte20-like kinase SLK, at the crossroads: a matter of life and deathEarly response to ErbB2 over-expression in polarized Caco-2 cells involves partial segregation from ErbB3 by relocalization to the apical surface and initiation of survival signaling.LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway.Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins.Functional analysis of Csk and CHK kinases in breast cancer cells.Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle.Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling
P2860
Q22000754-D166C9FF-77AE-4086-9248-57E788ACF13CQ24801546-5F6FAA59-F31F-4667-B7B4-22A0F52BB4C9Q28250940-85F247FA-C4D6-4BB1-8E67-69B16452169AQ28283309-5974EFFF-748B-49E0-AB98-521A8A56D112Q30480823-F4C85EAC-0A28-4BC2-A7DB-96C633F8FC6CQ33733727-2A24FED9-B3C2-4E02-870E-309133D063EBQ33940548-6CD40AC0-EE0B-4BF9-A388-5F0A575F8CE8Q34068051-6685E05F-512F-48C0-8A67-80E40B652A67Q34130558-5CFBA887-26D9-44AF-B54E-8F5C5CE6155DQ34160186-1FCE26C3-74C2-4DAA-9549-938224BEFBBFQ34169164-A9DD3555-9890-41B9-8848-C70A7AA2D73FQ34272277-14F1B850-6FAF-40C9-941A-3976EAB98419Q34468798-8B70479B-1162-4B41-A062-6EC83A732997Q34698008-20FC047A-2864-4450-86AD-B7CC2AA81CFBQ34727746-4899FCB5-078A-4657-9224-EFF1A4E1A003Q34768155-321A1C5C-9C8C-47A7-91CC-764E3ADC80BEQ34872645-B8301557-2F9E-4C0F-BABF-04B5A6FE0E62Q35012724-3F0D37CD-87BA-48E4-ACFE-58DA26FDB9CAQ35070697-080AA198-8384-489F-BBF0-60144BD7BBFAQ35166541-073D90CE-CA84-45E6-9469-B6BAEBFE4ABFQ35766061-CD9C5228-1075-42B5-AD39-E65E50A0ECFEQ37062541-795440C4-AF7A-4687-BA4A-DF2B55858902Q37350643-8CEF46E2-E291-4EE6-87AD-1B1D9841941CQ37415729-9BE63615-1F3E-48A4-8EF1-67DC4A589300Q37564758-616381D4-9020-4EEB-B0C0-FC9F52511265Q37588287-522468BD-B6AC-4894-A4F3-981569D51D5EQ38060063-9267F45A-5104-494E-9BD1-6B74F718FD69Q39686854-977096AE-6176-47F3-9237-F2C9CD96F720Q39817827-1D8DB91F-DE34-4160-BEDD-8351FC71C2F1Q39838037-6FAEDAC9-503A-4E15-809A-63D0D946EDB4Q40715312-1840A2B6-EEEA-4829-B0E1-F215745FAA50Q40786730-181A387A-0F08-47B6-90C0-2A99CC0F548FQ40793615-9EAB5F04-3EC0-441B-B5E6-D7308D64E1A6Q43713956-A0CA10EB-0452-485C-81BD-7D9C5F27CCD6Q49413628-CF49A485-410B-4E91-A258-1369B286C4ACQ57117060-0940B2F1-E23D-40EA-AD36-E34003624323
P2860
Signal transduction in mammary tumorigenesis: a transgenic perspective.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Signal transduction in mammary tumorigenesis: a transgenic perspective.
@ast
Signal transduction in mammary tumorigenesis: a transgenic perspective.
@en
type
label
Signal transduction in mammary tumorigenesis: a transgenic perspective.
@ast
Signal transduction in mammary tumorigenesis: a transgenic perspective.
@en
prefLabel
Signal transduction in mammary tumorigenesis: a transgenic perspective.
@ast
Signal transduction in mammary tumorigenesis: a transgenic perspective.
@en
P2860
P356
P1433
P1476
Signal transduction in mammary tumorigenesis: a transgenic perspective.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203272
P407
P577
2000-02-01T00:00:00Z
P5875
P6179
1000299922